Darya-Varia Laboratoria Tbk Asset Resilience Ratio
Darya-Varia Laboratoria Tbk asset resilience ratio. Darya-Varia Laboratoria Tbk (DVLA) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See DVLA cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Darya-Varia Laboratoria Tbk (2008–2024)
Asset resilience ratio of Darya-Varia Laboratoria Tbk from 2008 to 2024. This chart shows how Darya-Varia Laboratoria Tbk's Asset Resilience Ratio has changed over time. Read Darya-Varia Laboratoria Tbk (DVLA) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Darya-Varia Laboratoria Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Darya-Varia Laboratoria Tbk asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Darya-Varia Laboratoria Tbk maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Darya-Varia Laboratoria Tbk Industry Peers by Asset Resilience Ratio
Compare Darya-Varia Laboratoria Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Darya-Varia Laboratoria Tbk Asset Resilience Ratio by Year (2008–2024)
Darya-Varia Laboratoria Tbk asset resilience ratio by year from 2008 to 2024. The table below shows the annual Asset Resilience Ratio data for Darya-Varia Laboratoria Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | Rp0.00 ≈ $0.00 |
Rp2.16 Trillion ≈ $126.66 Million |
-- |
| 2023-12-31 | 0.64% | Rp13.00 Billion ≈ $761.75K |
Rp2.04 Trillion ≈ $119.66 Million |
+2.75pp |
| 2022-12-31 | -2.11% | Rp-42.43 Billion ≈ $-2.49 Million |
Rp2.01 Trillion ≈ $117.73 Million |
+0.05pp |
| 2021-12-31 | -2.16% | Rp-45.04 Billion ≈ $-2.64 Million |
Rp2.09 Trillion ≈ $122.23 Million |
-2.79pp |
| 2020-12-31 | 0.63% | Rp12.59 Billion ≈ $737.60K |
Rp1.99 Trillion ≈ $116.41 Million |
+4.82pp |
| 2019-12-31 | -4.19% | Rp-76.61 Billion ≈ $-4.49 Million |
Rp1.83 Trillion ≈ $107.23 Million |
-8.88pp |
| 2018-12-31 | 4.69% | Rp79.00 Billion ≈ $4.63 Million |
Rp1.68 Trillion ≈ $98.61 Million |
-14.08pp |
| 2017-12-31 | 18.77% | Rp308.00 Billion ≈ $18.05 Million |
Rp1.64 Trillion ≈ $96.15 Million |
+18.27pp |
| 2016-12-31 | 0.50% | Rp7.71 Billion ≈ $451.51K |
Rp1.53 Trillion ≈ $89.73 Million |
+0.04pp |
| 2015-12-31 | 0.47% | Rp6.43 Billion ≈ $376.59K |
Rp1.38 Trillion ≈ $80.64 Million |
+0.06pp |
| 2014-12-31 | 0.41% | Rp5.08 Billion ≈ $297.92K |
Rp1.24 Trillion ≈ $72.44 Million |
-0.14pp |
| 2013-12-31 | 0.55% | Rp6.50 Billion ≈ $381.07K |
Rp1.19 Trillion ≈ $69.73 Million |
+0.27pp |
| 2012-12-31 | 0.28% | Rp3.01 Billion ≈ $176.36K |
Rp1.07 Trillion ≈ $62.97 Million |
+0.03pp |
| 2009-12-31 | 0.25% | Rp1.98 Billion ≈ $115.90K |
Rp783.61 Billion ≈ $45.92 Million |
+0.08pp |
| 2008-12-31 | 0.17% | Rp1.08 Billion ≈ $63.51K |
Rp637.66 Billion ≈ $37.36 Million |
-- |
About Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women hea… Read more